Jiangsu Lianhuan Pharmaceutical Co., Ltd. Class ASSE: 600513

"Jiangsu Lianhuan Pharmaceutical Co., Ltd."Announcement on the Proposed Selection of the Company and Controlled Subsidiary in the 12th Batch of National Centralized Drug Procurement

Aug 4, 2026 · Issued by Jiangsu Lianhuan Pharmaceutical Co., Ltd. Class A via Shanghai Stock Exchange

Announcement on the Proposed Selection of the Company and Controlled Subsidiary in the 12th Batch of National Centralized Drug Procurement

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference:
View Attachment

Company analysis

Earlier from Jiangsu Lianhuan Pharmaceutical Co., Ltd. Class A

"Jiangsu Lianhuan Pharmaceutical Co., Ltd."Investor Relations Activity Record FormJul 28
"Jiangsu Lianhuan Pharmaceutical Co., Ltd."Announcement on the Company's Receipt of the Approval for Marketing of a Chemical APIJul 23
"Jiangsu Lianhuan Pharmaceutical Co., Ltd."Announcement on Execution of the "Project Entry Agreement" by the Company and Its Controlled Subsidiary and the Progress of External InvestmentJul 22
"Jiangsu Lianhuan Pharmaceutical Co., Ltd."Announcement on Acquisition of Drug Registration Certificate by a Controlled SubsidiaryJul 17

All Jiangsu Lianhuan Pharmaceutical Co., Ltd. Class A news releases